AeroScout Acquires Sentient Health

AeroScout®, the leading provider of Unified Asset Visibility solutions for the healthcare industry, has acquired Sentient Health, which provides hospitals with software and services for optimizing inventory management of consumable medical supplies. The acquisition complements and builds on AeroScout's extensive portfolio of healthcare solutions that hospitals around the world rely on to increase operational efficiency and improve patient safety and care.

According to a report by the independent, not-for-profit standards organization GS1 UK, the top two technologies identified by nurses to help them improve efficiency and patient safety were: 1.) technologies that provide real-time views of stock levels (63 percent); and 2.) technologies for tracking the location of equipment electronically (56 percent). With its acquisition of Sentient Health, AeroScout now offers solutions and is a leader in both of these areas: AeroScout's Asset Tracking and Management solution and Sentient Health's MedTrac solution for supply chain visibility.

Hospitals use Sentient Health's MedTrac software to automate supply chain management of consumable medical supplies, such as stents, syringes and gloves. Tracking these items is a complex and time-consuming process that is typically handled manually by hospital staff. The manual approach, however, is inefficient and error-prone, which drives up costs and diverts time away from caring for patients. With MedTrac, healthcare providers are able to manage their inventories and automate procurement, increasing efficiency while reducing operating costs and saving staff time.

Many National Health Service (NHS) Trust hospitals in the U.K., including Barts and The London NHS Trust, North Bristol NHS Trust, Southampton University Hospital NHS Trust, Cardiff and Vale NHS Trust, Royal Brompton & Harefield Foundation NHS Trust, as well as Omori Red Cross Hospital, Omuta City Hospital and Osaka Mishima Emergency Medical Center in Japan, are using and benefiting from MedTrac. Sentient Health customers also include top healthcare logistics companies, DHL in Europe and Toho Pharmaceutical Co., Ltd. in Japan.

"Using MedTrac has meant that staff has more time to spend running the department and caring for patients rather than concentrating on inventory management and stock control," said Helen Sack, Clinical Coordinator at North Bristol NHS Trust.

AeroScout is the leader in Healthcare Visibility Solutions, with over 450 hospital customers worldwide. AeroScout is proud to report that in a 2010 evaluation of healthcare providers conducted by KLAS, 100 percent of AeroScout customers that responded to the survey said they would purchase AeroScout again.* Its Wi-Fi RFID solutions have also received the exclusive endorsement of the American Hospital Association.

"AeroScout continues to extend its leadership position in healthcare, with strong demand for our healthcare visibility solutions worldwide," said Yuval Bar-Gil, CEO of AeroScout. "The acquisition of Sentient Health adds supply chain visibility and optimization to our portfolio, as well as the expertise of the Sentient Health team, to support more of the needs of our healthcare customers and further extend our leadership in healthcare."

The companies have not disclosed the terms of the acquisition.

About AeroScout
AeroScout is the global market leader in Unified Asset Visibility solutions. Customers improve operational efficiency using AeroScout products that leverage standard Wi-Fi networks to track and manage the location, condition and status of mobile assets and people. AeroScout's customer base consists of leading hospital, manufacturing, mining and logistics organizations, including many of the Fortune 500. The company invented the first Wi-Fi–based Active RFID tag, and today is widely recognized as leading the market in number of deployments. Headquartered in Redwood City, California, AeroScout has offices in Europe, the Middle East, Asia, Australia and Latin America.

* The evaluation, 2010 Top 20 Best in KLAS Awards, was published in December 2010.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...